The effects of subdermal implantation of levonorgestrel (LNG) on repro
duction were studied in domestic cats (Felis domestica). Levonorgestre
l was administered via a slow-release subdermal silastic implant to 10
queens. The implants contained 16 mg of LNG and were designed to rele
ase 60 mu g of the drug daily. Each treated queen received one implant
. Five queens (control, group 1) received subdermal silastic implants
containing no drug. Changes in body weight, mammary gland structure (d
etermined by palpation), serum blood glucose concentrations, and repro
ductive factors (occurrence of estrous cycles, serum progesterone conc
entrations, and pregnancy) were monitored for 1 year Four treated quee
ns (treatment/recovery, group 2) were used to investigate reproductive
function following 12 months of LNG treatment. Ib assess effects of t
reatment on macroscopic and microscopic anatomic features of reproduct
ive and nonreproductive tissues, the remaining six cats (treatment/his
tology, group 3) were studied. Hemiovariohysterectomy was performed in
two queens each at 0, 2, and 6 months of the study. Later, the remain
der of the reproductive tract was harvested at necropsy (two after 2 m
onths of treatment, two after 6 months, two after 12 months) to assess
change in individual queens. Nonreproductive tissues were also examin
ed at necropsy to determine effects of LNG: in these six queens. All q
ueens retained the implants during the period of study without detecta
ble discomfort. Estrus was suppressed and no pregnancies were recorded
in the four LNG-treated cats that were housed with a male. Treatment
with LNG had no effect on body weight, physical mammary gland structur
e, or serum blood glucose concentrations. All untreated queens (group
1) displayed estrous behavior and nine pregnancies resulted. Serum pro
gesterone concentrations in untreated queens characteristically increa
sed during pregnancy and decreased at parturition. Serum progesterone
concentrations in each treated queen (groups 2 and 3) remained at basa
l levels (<1.0 ng/ml) throughout the treatment period. This may have b
een due to anovulation or defective luteal function. Following removal
of the implant after 1 year three of four queens (group 2) exhibited
estrus and conceived within 54 days. Histologic examination revealed c
orpora lutea in the ovaries of two queens (group 3) at the end of 12 m
onths of treatment. Changes in 9 of the 10 uterine horns examined afte
r treatment was begun included glandular epithelial hypertrophy and hy
perplasia in addition to glandular proliferation and branching, sugges
tive of a progestational response. Small numbers of endometrial cysts
were present in one of these uterine horns harvested after 2 months of
treatment. In the tenth uterine horn examined, harvested after 6 mont
hs of treatment, some characteristics of pyometra were detected. No ma
croscopic or microscopic lesions were found in mammary gland tissues (
five of five subjects) examined. No other macroscopic or microscopic c
hanges in tissues harvested at necropsy could be attributed to LNG adm
inistration. The results indicate that subcutaneous administration of
LNG, delivered by means of a slow-release silastic implant, may consti
tute an effective, safe, and reversible method of contraception in the
domestic cat.